Numerous molecular biomarkers have been proposed to predict outcome in SM, including PfHRP2 concentrations, var gene expression profiles, sTREM-1, sFlt-1, and angiopoietins 1 and 2. Here, ANGPT1 is linked to systemic mastocytosis.